Who owns AVENUE THERAPEUTICS INC?
- Ticker: ATXI
- CUSIP Number: 05360l304
Tip: Access positions for across all investors
Analyze quarterly positions in Avenue Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avenue Therapeutics stock
Who bought or sold AVENUE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 89k | $14k | 100% | Dec 2023 |
|
| Vanguard Group | 46k | $7.5k | 0% | Dec 2023 |
|
| Millennium Management | 29k | $4.6k | 100% | Dec 2023 |
|
| Two Sigma Securities | 28k | $4.4k | 90% | Dec 2023 |
|
| Hrt Financial | 25k | $4.0k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 11k | $1.8k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 4.6k | $762.035200 | 1% | Dec 2023 |
|
| UBS Group | 1.1k | $173.988000 | 100% | Dec 2023 |
|
| Emfo | 533.00 | $86.026200 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 514.00 | $0 | 424% | Dec 2023 |
|
Who sold out of Avenue Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of New York Mellon | Sep 2023 | 52k | $37k |
| Shikiar Asset Management | Sep 2023 | 13k | $9.0k |